Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

Fasenra receives approval in Japan
19 January 2018
Lynparza approved by US FDA in germline BRCA-mutated metastatic breast cancer
12 January 2018
AstraZeneca receives EU approval of Fasenra for severe eosinophilic asthma
10 January 2018
US FDA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
18 December 2017
AstraZeneca to highlight its commitment to blood cancers at the 2017 American Society of Hematology Annual Meeting
6 December 2017
Tudorza reduces exacerbations and demonstrates cardiovascular safety in COPD patients
4 December 2017
The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
28 November 2017
AstraZeneca makes regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer in Japan
27 November 2017
AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China
27 November 2017
Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib
15 November 2017

<
43
44
45
46
47
48
49
111
>

All of our latest press releases and articles are available to explore